Angiogenic Gene Therapy for the Treatment of Retinopathies

  title={Angiogenic Gene Therapy for the Treatment of Retinopathies},
  author={Jacob M. Jones and Trevor J McFarland and Jeffrey T. Stout},
In the past decade, advances in vector design and delivery have helped guide gene therapy technologies from the laboratory to clinical trials. These technologies are poised to tackle a key problem in opthalmology: pathologic angiogenesis. Gene transfer techonologies offer the potential for highly regulated and sustained delivery of a therapeutic agent, and may have the potential to arrest a pathological process prior to the evolution of a soluble angiogenic factor. Multiple biologic effectors… CONTINUE READING